Literature DB >> 15661528

Understanding transformation: progress and gaps.

Jesse S Boehm1, William C Hahn.   

Abstract

Cancer is a collection of complex genetic diseases characterized by multiple defects in the homeostatic mechanisms that regulate cell growth, proliferation and differentiation. Although the analysis of human tumor specimens has allowed the identification of many molecules and pathways important for the malignant phenotype, we still lack a complete understanding of the events that conspire to program any specific type of cancer. Recent advances in developing human experimental models of cancer have provided new insights into the pathways whose perturbation is necessary to achieve cell transformation. These studies indicate that many combinations of genetic mutations confer tumorigenicity on human cells and that both cell-type and tumor-stromal interactions play critical roles in dictating the tumor phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661528     DOI: 10.1016/j.gde.2004.11.003

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  11 in total

Review 1.  What has senescence got to do with cancer?

Authors:  Goberdhan P Dimri
Journal:  Cancer Cell       Date:  2005-06       Impact factor: 31.743

2.  The HBP1 transcriptional repressor participates in RAS-induced premature senescence.

Authors:  Xiaowei Zhang; Jiyoung Kim; Robin Ruthazer; Michael A McDevitt; David E Wazer; K Eric Paulson; Amy S Yee
Journal:  Mol Cell Biol       Date:  2006-09-11       Impact factor: 4.272

3.  Iron-binding proteins and C-reactive protein in Nipple Aspirate Fluids: role of Iron-driven inflammation in breast cancer microenvironment?

Authors:  Ferdinando Mannello; Gaetana A Tonti; Patrizia Simone; Daniela Ligi; Virginia Medda
Journal:  Am J Transl Res       Date:  2010-10-30       Impact factor: 4.060

4.  Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways.

Authors:  Sonal Datta; Mark J Hoenerhoff; Prashant Bommi; Rachana Sainger; Wei-Jian Guo; Manjari Dimri; Hamid Band; Vimla Band; Jeffrey E Green; Goberdhan P Dimri
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

5.  Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells.

Authors:  Nuri Ozturk; Esra Erdal; Mine Mumcuoglu; Kamil C Akcali; Ozden Yalcin; Serif Senturk; Ayca Arslan-Ergul; Bala Gur; Isik Yulug; Rengul Cetin-Atalay; Cengiz Yakicier; Tamer Yagci; Mesut Tez; Mehmet Ozturk
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

6.  Mammalian cells acquire epigenetic hallmarks of human cancer during immortalization.

Authors:  Stella Tommasi; Albert Zheng; Annette Weninger; Steven E Bates; Xuejun Arthur Li; Xiwei Wu; Monica Hollstein; Ahmad Besaratinia
Journal:  Nucleic Acids Res       Date:  2012-11-11       Impact factor: 16.971

7.  Interferon-β induces cellular senescence in cutaneous human papilloma virus-transformed human keratinocytes by affecting p53 transactivating activity.

Authors:  Maria V Chiantore; Serena Vannucchi; Rosita Accardi; Massimo Tommasino; Zulema A Percario; Gabriele Vaccari; Elisabetta Affabris; Gianna Fiorucci; Giovanna Romeo
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

8.  Drug treatment of cancer cell lines: a way to select for cancer stem cells?

Authors:  Ilaria Chiodi; Cristina Belgiovine; Francesca Donà; A Ivana Scovassi; Chiara Mondello
Journal:  Cancers (Basel)       Date:  2011-03-04       Impact factor: 6.639

9.  Pre-Treatment of platinum resistant ovarian cancer cells with an MMP-9/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screening.

Authors:  Alexandros Laios; Bashir M Mohamed; Lynn Kelly; Richard Flavin; Stephen Finn; Lynda McEvoy; Michael Gallagher; Cara Martin; Orla Sheils; Martina Ring; Anthony Davies; Margaret Lawson; Noreen Gleeson; Tom D'Arcy; Charles d'Adhemar; Lucy Norris; Ream Langhe; Feras Abu Saadeh; John J O'Leary; Sharon A O'Toole
Journal:  Int J Mol Sci       Date:  2013-01-22       Impact factor: 5.923

Review 10.  Resistance to chemotherapy: new treatments and novel insights into an old problem.

Authors:  S Raguz; E Yagüe
Journal:  Br J Cancer       Date:  2008-08-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.